Dr Melonie Romina Palmer, DPM | |
1004 Society Dr, Palmer Podiatry, Claymont, DE 19703-1782 | |
(302) 792-1961 | |
(302) 792-1981 |
Full Name | Dr Melonie Romina Palmer |
---|---|
Gender | Female |
Speciality | Podiatry |
Experience | 35 Years |
Location | 1004 Society Dr, Claymont, Delaware |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1275626558 | NPI | - | NPPES |
0440231000 | Other | PA | BLUE SHIELD HMO ID# |
0000878817 | Medicaid | DE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
213E00000X | Podiatrist | E1-0000131 (Delaware) | Primary |
213E00000X | Podiatrist | SC003464R (Pennsylvania) | Secondary |
Mailing Address | Practice Location Address |
---|---|
Dr Melonie Romina Palmer, DPM 10 Basswood Ln, Wilmington, DE 19810-1927 Ph: (302) 792-1961 | Dr Melonie Romina Palmer, DPM 1004 Society Dr, Palmer Podiatry, Claymont, DE 19703-1782 Ph: (302) 792-1961 |
News Archive
NICE (National Institute for Health and Care Excellence) has announced a new Medtech Innovation Briefing (MIB) stating that NHS doctors and commissioners may consider Single Dose Intraoperative Radiotherapy (SD-IORT) using the Xoft Axxent electronic brachytherapy system with ORL managed service as a treatment option for early stage breast cancer patients.
Alacrita, which is changing the face of life science consulting, has published an insight into the future development of the global pharmaceutical industry.
Arisaph Pharmaceuticals, Inc., a privately held biopharmaceutical company focused on discovery and development of novel therapies for cardiometabolic diseases and cancer, announced today that it has been awarded a phase II Small Business Technology Transfer (STTR) grant and a supplemental phase I grant, both from the National Cancer Institute of the National Institutes of Health.
Kibow Biotech, Inc., Pennsylvania, will feature its product for Kidney Illness, RENADYLâ„¢, at the 50th Anniversary Meeting of the American Nephrology Nurse Association (ANNA) in Dallas, Texas, USA.
An international research team has discovered a gene that, when mutated, causes one of the most common forms of inherited blindness in babies.
› Verified 3 days ago